XML 75 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2012
Operating activities      
Net income $ 30.2 $ 50.1 $ 29.9
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 29.6 50.1 29.9
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation 57.7 61.3 63.1
Amortization of intangible assets 50.8 51.1 50.9
Amortization of deferred financing costs 2.6 3.9 7.8
Loss (gain) on dispositions of property, plant and equipment 2.3 (3.6) 1.2
Non-cash loss on divestiture 0 0 4.5
Non-cash restructuring charges 0 0 4.6
Deferred income taxes (24.9) (15.4) (22.2)
Other non-cash (credits) charges (0.1) 7.3 14.8
Loss on extinguishment of debt (133.2) (24.0) (10.7)
Stock-based compensation expense 7.0 7.1 3.7
Changes in operating assets and liabilities:      
Receivables (11.3) (20.3) (33.8)
Inventories (11.3) (12.8) (3.4)
Other assets (6.8) 7.5 (10.7)
Accounts payable 26.0 (4.3) 22.3
Accruals and other (64.0) (11.4) (4.1)
Cash provided by operating activities 190.8 144.5 139.3
Investing activities      
Expenditures for property, plant and equipment (52.2) (60.1) (58.5)
Acquisitions, net of cash acquired (112.0) (21.0) (256.8)
Loan receivable for financing under New Market Tax Credit incentive program 0 (9.7) (17.9)
Proceeds from dispositions of property, plant and equipment 0.4 6.7 5.6
Proceeds from divestiture, net of cash 0 2.3 3.4
Cash used for investing activities (163.8) (81.8) (324.2)
Financing activities      
Proceeds from borrowings of long-term debt 1,935.1 15.4 960.6
Repayments of long-term debt (1,948.4) (313.2) (762.0)
Proceeds from borrowings of short-term debt 13.5 12.6 10.7
Repayments of short-term debt (165.6) (8.2) (105.0)
Payment of deferred financing fees (17.1) (2.0) (13.2)
Payment of tender premium (109.9) (17.6) 0
Proceeds from issuance of common stock, net of direct offering costs 73.8 458.3 2.1
Proceeds from exercise of stock options 2.1 2.3 0
Proceeds from Noncontrolling Interests 0.4 0 0
Excess tax benefit on exercise of stock options 5.8 18.1 0
Cash (used for) provided by financing activities (210.3) 165.7 93.2
Effect of exchange rate changes on cash and cash equivalents (1.8) (2.3) (1.3)
(Decrease) increase in cash and cash equivalents (185.1) 226.1 (93.0)
Cash and cash equivalents at beginning of period 524.1 298.0  
Cash and cash equivalents at end of period $ 339.0 $ 524.1 $ 298.0